These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15466851)

  • 41. Identifying Barriers to the Treatment of Chronic Hepatitis C Infection.
    Al-Khazraji A; Patel I; Saleh M; Ashraf A; Lieber J; Malik R
    Dig Dis; 2020; 38(1):46-52. PubMed ID: 31422405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clients' perceptions of barriers and facilitators to implementing hepatitis C virus care in homeless shelters.
    Masson CL; Fokuo JK; Anderson A; Powell J; Zevin B; Bush D; Khalili M
    BMC Infect Dis; 2020 May; 20(1):386. PubMed ID: 32471376
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis C testing in substance use disorder treatment: the role of program managers in adoption of testing services.
    Frimpong JA; D'Aunno T
    Subst Abuse Treat Prev Policy; 2016 Apr; 11():13. PubMed ID: 27036115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Adolescent Community Reinforcement Approach (A-CRA) as a model paradigm for the management of adolescents with substance use disorders and co-occurring psychiatric disorders.
    Godley SH; Smith JE; Passetti LL; Subramaniam G
    Subst Abus; 2014; 35(4):352-63. PubMed ID: 25035906
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hepatitis C in a psychiatric setting: A forgotten reservoir?].
    Rolland B; Bailly F; Cutarella C; Drevon O; Carrieri P; Darque A; Hallouche N; Maptue N; Pol S; Llorca PM; Lang JP
    Encephale; 2021 Apr; 47(2):181-184. PubMed ID: 32473777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mental disorders in HIV/HCV coinfected patients under antiviral treatment for hepatitis C.
    Martin-Subero M; Diez-Quevedo C
    Psychiatry Res; 2016 Dec; 246():173-181. PubMed ID: 27718466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Background and overview of mental health and substance abuse treatment systems: meeting the needs of women who are pregnant or parenting.
    Grella CE
    J Psychoactive Drugs; 1996; 28(4):319-43. PubMed ID: 9017555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel program for treating patients with trimorbidity: hepatitis C, serious mental illness, and active substance use.
    Sockalingam S; Blank D; Banga CA; Mason K; Dodd Z; Powis J
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1377-84. PubMed ID: 23680911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Explaining differences in hepatitis C between U.S. veterans and nonveterans in treatment for substance abuse: results from a regression decomposition.
    Heslin KC; Guerrero EG; Mitchell MN; Afable MK; Dobalian A
    Subst Use Misuse; 2013 Jul; 48(10):854-62. PubMed ID: 23869458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis C virus and depression in drug users.
    Johnson ME; Fisher DG; Fenaughty A; Theno SA
    Am J Gastroenterol; 1998 May; 93(5):785-9. PubMed ID: 9625128
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance.
    Martinez AD; Dimova R; Marks KM; Beeder AB; Zeremski M; Kreek MJ; Talal AH
    J Viral Hepat; 2012 Jan; 19(1):47-54. PubMed ID: 21129131
    [TBL] [Abstract][Full Text] [Related]  

  • 52. National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C.
    Hepatology; 1997 Sep; 26(3 Suppl 1):2S-10S. PubMed ID: 9305656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Time to rethink antiviral treatment for hepatitis C in patients with coexisting mental health/substance abuse issues.
    Bonner JE; Barritt AS; Fried MW; Evon DM
    Dig Dis Sci; 2012 Jun; 57(6):1469-74. PubMed ID: 22484494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Ettner SL;
    J Acquir Immune Defic Syndr; 2008 Apr; 47(4):449-58. PubMed ID: 18197121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States.
    Bini EJ; Kritz S; Brown LS; Robinson J; Calsyn D; Alderson D; Tracy K; McAuliffe P; Smith C; Rotrosen J
    J Subst Abuse Treat; 2012 Jun; 42(4):438-45. PubMed ID: 22035702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study.
    Sundberg I; Lannergård A; Ramklint M; Cunningham JL
    BMC Psychiatry; 2018 May; 18(1):157. PubMed ID: 29843679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Staff perspectives on facilitating the implementation of hepatitis C services at drug treatment programs.
    Munoz-Plaza CE; Strauss SM; Astone-Twerwll JM; Des Jarlais DC; Hagan H
    J Psychoactive Drugs; 2006 Sep; 38(3):233-41. PubMed ID: 17165366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The clinical management of co-morbidity.
    Pols RG
    Alcohol Alcohol Suppl; 1994; 2():485-90. PubMed ID: 8974372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increasing antiviral treatment through integrated hepatitis C care: a randomized multicenter trial.
    Groessl EJ; Sklar M; Cheung RC; Bräu N; Ho SB
    Contemp Clin Trials; 2013 Jul; 35(2):97-107. PubMed ID: 23669414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis C in injection drug users: It is time to treat.
    Grassi A; Ballardini G
    World J Gastroenterol; 2017 May; 23(20):3569-3571. PubMed ID: 28611509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.